During the past decade, Greenwood Genetic Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Greenwood Genetic Center" #1 sponsor was "Zynerba Pharmaceuticals, Inc." with 4 trials, followed by "ACADIA Pharmaceuticals Inc." with 3 trials sponsored, "University of Alabama at Birmingham" with 3 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored and "Neuren Pharmaceuticals Limited" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Greenwood Genetic Center" #1 collaborator was "Greenwood Genetic Center" with 7 trials as a collaborator, "Baylor College of Medicine" with 5 trials as a collaborator, "Boston Children's Hospital" with 4 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator and "Rady Children's Hospital, San Diego" with 3 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Greenwood Genetic Center" are "Rett Syndrome" (10 trials), "Fragile X Syndrome" (6 trials), "Angelman Syndrome" (4 trials), "Fabry Disease" (2 trials) and "Intellectual Disability" (2 trials). Many other conditions were trialed in "Greenwood Genetic Center" in a lesser frequency.

Most popular intervention types in "Greenwood Genetic Center" are "Drug" (16 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Lucerastat" (2 trials), "NNZ-2566" (2 trials), "Trofinetide" (2 trials) and "ZYN002 - Cannabidiol Transdermal Gel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Greenwood Genetic Center" are 19 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Greenwood Genetic Center". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Greenwood Genetic Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Greenwood Genetic Center, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".